Schedule 13G ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: 2016-03-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 121,899
- Percent of class
- 1.7600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-16-000085
- Form type
- SC 13G
- Filer
- Eiger BioPharmaceuticals, Inc.
- CIK
- CIK 1305253
- Filed
- Apr 04, 2016
- Reporting period
- Mar 22, 2016
- Description
- Schedule 13G beneficial ownership